Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Bitcoin and Blockchain Stocks


Legal Marijuana Sales to Grow 33% to $10 Billion in 2017 Exceeds Arcview's previous growth estimate

 

Oakland, California - December 6, 2017 (Investorideas.com Newswire) Consumer spending on legal cannabis in North America is outpacing previous estimates, according to a new report out today from Arcview Market Research. According to the just released Mid-Year Update to The State of Legal Marijuana Markets 5th Edition, retail cannabis sales will grow 33% from 2016 to nearly $10 billion this year. By 2021 Arcview projects the legal market to reach $24.5 billion, a 28% compound annual growth rate (CAGR). The full original 200+ page report, as well as this 100+ page supplement to the original report, published by Arcview Market Research in partnership with BDS Analytics, is available for $597.

The report notes that despite continued federal prohibition, North American consumers continue to rapidly transition their cannabis consumption out of the illicit market and into state-sanctioned retail stores.

Among other findings, the Mid-Year Update revealed:

  • California's medical market is already as big as the total markets in Colorado, Washington, and Oregon combined, according to BDS Analytics' GreenEdge point-of-sale tracking service, which added California to its databanks over the summer.
  • Nevada retailers were allowed to open sales to all adults earlier than expected, and generated more than $27 million the first month of adult-use sales, according to the Nevada Department of Taxation.
  • International markets saw major advances in 2017, including the launch of a medical cannabis program for Germany's population of 82 million people.
  • Despite a pullback by the stocks of US-based publicly traded cannabis-related companies, investment continued to pour into the cannabis business, including the C$101 million IPO of Canadian licensed producer MedReleaf, the largest ever cannabis-related IPO.

"Aside from cryptocurrency, there is simply no other industry changing as rapidly or as unevenly as the cannabis sector," said Troy Dayton, CEO of The Arcview Group. "That makes capturing the data, predicting consumer behavior, and forecasting political developments both extraordinarily difficult and complicated, and one of the most vital tools for investors, entrepreneurs, and regulators trying to make sense of it all."

"Our data shows positive indicators across the board for the legal cannabis industry, in North America and around the globe," said Tom Adams, Editor-in-Chief at Arcview Market Research and Principal Analyst at BDS Analytics. "The passage of the 2016 ballot initiatives and continued maturation of the existing Adult-Use markets are the primary drivers of the growth this year. That's nothing compared to what we can expect in 2018 and beyond from Nevada's tourism, and California and Canada planning to launch Adult-Use sales in 2018."

The Mid-Year Update also explores the positioning of Canadian licensed producers as they prepare for full adult-use legalization in July 2018, as well as an analysis of trends surrounding private investments in the U.S. cannabis market.

For more information, or to purchase The 2017 Mid-Year Update to The State of Legal Marijuana Markets 5th Edition, please visit arcviewgroup.com/research.

About The Arcview Group:

Founded in 2010, The Arcview Group is responsible for a number of groundbreaking ventures in the cannabis industry. The Arcview Investor Network includes more than 600 accredited investors who have put more than $150 million behind 165 companies. Arcview Market Research has published the State of Legal Marijuana Markets since 2011 and it has become the most oft-cited data in the sector. In 2017, Arcview Market Research partnered with BDS Analytics to add more robust point-of-sale data and consumer insights to its offerings. In 2015 Arcview became a partner in Canopy, the first seed-stage mentor-driven business accelerator. Arcview is also co-founder of Cannasure Insurance Services, the leading provider of business insurance to the cannabis industry. Forbes Magazine recently named Arcview among the top 5 financial firms in the cannabis sector.

About BDS Analytics:


Headquartered in Boulder, Colo., BDS Analytics provides cannabis brands, cultivators, producers, dispensaries, and investors with comprehensive, actionable, and accurate cannabis market intelligence and consumer research. The company provides a holistic understanding of the cannabis market by producing insights from dispensary point-of-sale systems through its market-leading GreenEdgeTM platform and driving consumer research with its Cannabis Insights Group. To learn more about how you can utilize BDS Analytics' superior data and insights, please visit www.bdsanalytics.com.

Media Contact Information:

Arcview Market Research
Abby Benjamin
abbybenjamin@arcviewgroup.com

BDS Analytics
Robert Vanisko – North 6th Agency
bdsanalytics@n6a.com
212-334-9753 ext. 112

Disclosure: The Arcview Group is featured on the 420 Cannabis Investor Ideas Directory at www.420cannabisinvestorideas.com


Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks



Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing



More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Questrade Democratic Pricing - 1 cent per share, $4.95 min / $9.95 max



Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner